BD Bioscience today launched a new cloud-based system called ‘BD Synapsys Microbiology Informatics Solution’ to facilitate faster diagnostic results and improve infectious disease management.
A new study documents, for the first time, how the ability of bacteria to swap genetic material with each other can directly affect the emergence and spread of globally important infectious diseases.
General Electric aims to build on its existing expertise in biotech manufacturing by delivering a “factory-in-a-box” service specifically for viral vector-based medicine.
Researchers have discovered a way to greatly improve the accuracy of gene-editing technology by replacing the natural guide molecule it uses with a synthetic one called a bridged nucleic acid, or BNA.
A new cancer cell-based assay could help doctors diagnose cancer, better monitor the disease, and take a step closer to customised treatment for individual patients.
Scientists have developed a straightforward, computational way to measure cellular age, a feat that may lead to better, simpler screening and monitoring methods for cancer and other diseases.
Experts in medicine and law are urging the US to allow for the replacement of mutation-bearing mitochondria to prevent fatal illnesses in children.